| Authors: |
Yu J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA., Qin B; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Moyer AM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA., Nowsheen S; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Medicine and the Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, 55905, USA., Tu X; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Dong H; Departments of Urology and Immunology, Mayo Clinic, Rochester, MN, 55905, USA., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA., Goetz MP; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Weinshilboum R; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA., Lou Z; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA. Lou.Zhenkun@mayo.edu., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA. Wang.Liewei@mayo.edu. |
